PDB Short entry for 4NZD HEADER SIGNALING PROTEIN 12-DEC-13 4NZD TITLE INTERLEUKIN 21 RECEPTOR CAVEAT 4NZD FUC D 5 HAS WRONG CHIRALITY AT ATOM C1 FUC E 5 HAS WRONG CAVEAT 2 4NZD CHIRALITY AT ATOM C1 FUC F 5 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTERLEUKIN-21 RECEPTOR; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: IL-21 RECEPTOR, IL-21R, NOVEL INTERLEUKIN RECEPTOR; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IL21R, NILR, UNQ3121/PRO10273; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HEK293 CELLS KEYWDS FIBRONECTINE III DOMAIN, INTERLEUKIN 21, GLYCOSYLATED, SIGNALING KEYWDS 2 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR O.T.HAMMING,L.KANG,P.SIUPKA,H.H.GAD,R.HARTMANN REVDAT 3 29-JUL-20 4NZD 1 CAVEAT COMPND REMARK SEQADV REVDAT 3 2 1 HETNAM LINK SITE ATOM REVDAT 2 07-MAR-18 4NZD 1 REMARK REVDAT 1 17-DEC-14 4NZD 0 JRNL AUTH O.T.HAMMING,L.KANG,P.SIUPKA,H.H.GAD,R.HARTMANN JRNL TITL INTERLEUKIN 21 RECEPTOR STRUCTURE AND FUNCTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.2_1309) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.78 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 33241 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.241 REMARK 3 R VALUE (WORKING SET) : 0.239 REMARK 3 FREE R VALUE : 0.275 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.010 REMARK 3 FREE R VALUE TEST SET COUNT : 1999 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.7800 - 6.6053 0.99 2359 151 0.1890 0.1775 REMARK 3 2 6.6053 - 5.2522 1.00 2300 147 0.1660 0.1723 REMARK 3 3 5.2522 - 4.5910 1.00 2261 145 0.1489 0.1779 REMARK 3 4 4.5910 - 4.1725 1.00 2277 146 0.1882 0.2245 REMARK 3 5 4.1725 - 3.8741 0.99 2221 141 0.2871 0.3333 REMARK 3 6 3.8741 - 3.6461 0.97 2163 138 0.3430 0.4061 REMARK 3 7 3.6461 - 3.4638 0.95 2130 137 0.2783 0.3026 REMARK 3 8 3.4638 - 3.3132 0.99 2207 142 0.3118 0.3371 REMARK 3 9 3.3132 - 3.1859 1.00 2237 143 0.2423 0.3232 REMARK 3 10 3.1859 - 3.0760 0.99 2199 140 0.2544 0.2947 REMARK 3 11 3.0760 - 2.9799 1.00 2245 144 0.2573 0.3370 REMARK 3 12 2.9799 - 2.8948 1.00 2235 143 0.2582 0.3313 REMARK 3 13 2.8948 - 2.8187 1.00 2214 141 0.2775 0.3721 REMARK 3 14 2.8187 - 2.7500 0.99 2194 141 0.2870 0.3872 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.380 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.980 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 5503 REMARK 3 ANGLE : 1.142 7510 REMARK 3 CHIRALITY : 0.076 846 REMARK 3 PLANARITY : 0.004 933 REMARK 3 DIHEDRAL : 22.856 2044 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 1 REMARK 3 NCS GROUP : 1 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4NZD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-JAN-14. REMARK 100 THE DEPOSITION ID IS D_1000083846. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : MAX II REMARK 200 BEAMLINE : I911-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.04 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DNA REMARK 200 DATA SCALING SOFTWARE : DNA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33261 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.750 REMARK 200 RESOLUTION RANGE LOW (A) : 29.780 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 70.57 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 5 MG/ML PROTEIN IN 10 MM HEPES, 150 MM REMARK 280 NACL, PH7.5 CRYSTALIZED IN 1M POTASSIUM SODIUM TARTRATE REMARK 280 TETRAHYDRATE, 3% W/V PEG5000 AND 0.1 M TRIS PH 8.5. DROPS WERE 1: REMARK 280 1, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 278K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 57.16500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 62.63000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 89.13500 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 57.16500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 62.63000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 89.13500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 57.16500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 62.63000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 89.13500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 57.16500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 62.63000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 89.13500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 39290 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 65100 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -293.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 -1.000000 0.000000 0.000000 57.16500 REMARK 350 BIOMT2 1 0.000000 -1.000000 0.000000 187.89000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 -89.13500 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 57.16500 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 -62.63000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 89.13500 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C, E, F REMARK 350 BIOMT1 3 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 3 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 4 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 4 0.000000 -1.000000 0.000000 125.26000 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 34 REMARK 465 GLN A 35 REMARK 465 TYR A 36 REMARK 465 GLU A 37 REMARK 465 GLU A 38 REMARK 465 LEU A 39 REMARK 465 LYS A 40 REMARK 465 ASP A 41 REMARK 465 HIS A 219 REMARK 465 GLU B 209 REMARK 465 GLU B 210 REMARK 465 LEU B 211 REMARK 465 LYS B 212 REMARK 465 GLU B 213 REMARK 465 HIS B 214 REMARK 465 HIS B 215 REMARK 465 HIS B 216 REMARK 465 HIS B 217 REMARK 465 HIS B 218 REMARK 465 HIS B 219 REMARK 465 GLN C 35 REMARK 465 TYR C 36 REMARK 465 GLU C 37 REMARK 465 GLU C 38 REMARK 465 LEU C 39 REMARK 465 LYS C 40 REMARK 465 ASP C 41 REMARK 465 GLU C 42 REMARK 465 HIS C 219 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 42 CG CD OE1 OE2 REMARK 470 LEU A 211 CG CD1 CD2 REMARK 470 LYS A 212 CG CD CE NZ REMARK 470 GLU A 213 CG CD OE1 OE2 REMARK 470 HIS A 218 CG ND1 CD2 CE1 NE2 REMARK 470 ALA B 102 CB REMARK 470 ASP C 34 CG OD1 OD2 REMARK 470 MET C 70 CG SD CE REMARK 470 LYS C 212 CG CD CE NZ REMARK 470 GLU C 213 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CD1 TRP B 195 C1 MAN B 301 1.47 REMARK 500 CD1 TRP C 195 C1 MAN C 301 1.54 REMARK 500 CD1 TRP A 195 C1 MAN A 301 1.58 REMARK 500 SG CYS A 46 CB CYS A 62 1.87 REMARK 500 OH TYR B 141 O HOH B 447 1.91 REMARK 500 OE1 GLU C 89 O HOH C 405 1.94 REMARK 500 O HOH B 458 O HOH B 459 2.03 REMARK 500 O HOH A 425 O HOH B 448 2.11 REMARK 500 O2 MAN F 4 O HOH C 456 2.12 REMARK 500 O HOH A 408 O HOH A 435 2.16 REMARK 500 O TYR B 36 O HOH B 446 2.16 REMARK 500 ND2 ASN A 54 C2 NAG D 1 2.17 REMARK 500 O3 TLA A 314 O HOH A 424 2.18 REMARK 500 OE1 GLN C 85 O HOH C 428 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 11 -97.48 -113.05 REMARK 500 THR A 44 -4.43 67.58 REMARK 500 ASN A 54 -151.41 -115.18 REMARK 500 PHE A 128 69.62 -108.89 REMARK 500 SER A 158 36.28 -85.20 REMARK 500 LEU A 211 145.94 -178.59 REMARK 500 HIS A 215 44.07 -107.76 REMARK 500 LEU B 11 -97.38 -112.40 REMARK 500 GLU B 37 15.85 45.37 REMARK 500 LYS B 40 -177.47 -69.69 REMARK 500 ASN B 54 -151.08 -116.72 REMARK 500 PHE B 128 72.65 -103.17 REMARK 500 SER B 158 35.33 -84.92 REMARK 500 LEU C 11 -96.90 -113.90 REMARK 500 ASN C 54 -151.37 -115.82 REMARK 500 PHE C 128 72.67 -105.94 REMARK 500 SER C 158 33.66 -85.59 REMARK 500 ASP C 174 57.13 33.85 REMARK 500 HIS C 214 55.68 -118.63 REMARK 500 HIS C 215 46.28 -94.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 MAN A 301 REMARK 610 MAN B 301 REMARK 610 MAN C 301 DBREF 4NZD A 1 213 UNP Q9HBE5 IL21R_HUMAN 20 232 DBREF 4NZD B 1 213 UNP Q9HBE5 IL21R_HUMAN 20 232 DBREF 4NZD C 1 213 UNP Q9HBE5 IL21R_HUMAN 20 232 SEQADV 4NZD GLN A 78 UNP Q9HBE5 ASN 97 CONFLICT SEQADV 4NZD GLN A 85 UNP Q9HBE5 ASN 104 CONFLICT SEQADV 4NZD ASP A 106 UNP Q9HBE5 ASN 125 CONFLICT SEQADV 4NZD GLN A 116 UNP Q9HBE5 ASN 135 CONFLICT SEQADV 4NZD HIS A 214 UNP Q9HBE5 EXPRESSION TAG SEQADV 4NZD HIS A 215 UNP Q9HBE5 EXPRESSION TAG SEQADV 4NZD HIS A 216 UNP Q9HBE5 EXPRESSION TAG SEQADV 4NZD HIS A 217 UNP Q9HBE5 EXPRESSION TAG SEQADV 4NZD HIS A 218 UNP Q9HBE5 EXPRESSION TAG SEQADV 4NZD HIS A 219 UNP Q9HBE5 EXPRESSION TAG SEQADV 4NZD GLN B 78 UNP Q9HBE5 ASN 97 CONFLICT SEQADV 4NZD GLN B 85 UNP Q9HBE5 ASN 104 CONFLICT SEQADV 4NZD ASP B 106 UNP Q9HBE5 ASN 125 CONFLICT SEQADV 4NZD GLN B 116 UNP Q9HBE5 ASN 135 CONFLICT SEQADV 4NZD HIS B 214 UNP Q9HBE5 EXPRESSION TAG SEQADV 4NZD HIS B 215 UNP Q9HBE5 EXPRESSION TAG SEQADV 4NZD HIS B 216 UNP Q9HBE5 EXPRESSION TAG SEQADV 4NZD HIS B 217 UNP Q9HBE5 EXPRESSION TAG SEQADV 4NZD HIS B 218 UNP Q9HBE5 EXPRESSION TAG SEQADV 4NZD HIS B 219 UNP Q9HBE5 EXPRESSION TAG SEQADV 4NZD GLN C 78 UNP Q9HBE5 ASN 97 CONFLICT SEQADV 4NZD GLN C 85 UNP Q9HBE5 ASN 104 CONFLICT SEQADV 4NZD ASP C 106 UNP Q9HBE5 ASN 125 CONFLICT SEQADV 4NZD GLN C 116 UNP Q9HBE5 ASN 135 CONFLICT SEQADV 4NZD HIS C 214 UNP Q9HBE5 EXPRESSION TAG SEQADV 4NZD HIS C 215 UNP Q9HBE5 EXPRESSION TAG SEQADV 4NZD HIS C 216 UNP Q9HBE5 EXPRESSION TAG SEQADV 4NZD HIS C 217 UNP Q9HBE5 EXPRESSION TAG SEQADV 4NZD HIS C 218 UNP Q9HBE5 EXPRESSION TAG SEQADV 4NZD HIS C 219 UNP Q9HBE5 EXPRESSION TAG SEQRES 1 A 219 CYS PRO ASP LEU VAL CYS TYR THR ASP TYR LEU GLN THR SEQRES 2 A 219 VAL ILE CYS ILE LEU GLU MET TRP ASN LEU HIS PRO SER SEQRES 3 A 219 THR LEU THR LEU THR TRP GLN ASP GLN TYR GLU GLU LEU SEQRES 4 A 219 LYS ASP GLU ALA THR SER CYS SER LEU HIS ARG SER ALA SEQRES 5 A 219 HIS ASN ALA THR HIS ALA THR TYR THR CYS HIS MET ASP SEQRES 6 A 219 VAL PHE HIS PHE MET ALA ASP ASP ILE PHE SER VAL GLN SEQRES 7 A 219 ILE THR ASP GLN SER GLY GLN TYR SER GLN GLU CYS GLY SEQRES 8 A 219 SER PHE LEU LEU ALA GLU SER ILE LYS PRO ALA PRO PRO SEQRES 9 A 219 PHE ASP VAL THR VAL THR PHE SER GLY GLN TYR GLN ILE SEQRES 10 A 219 SER TRP ARG SER ASP TYR GLU ASP PRO ALA PHE TYR MET SEQRES 11 A 219 LEU LYS GLY LYS LEU GLN TYR GLU LEU GLN TYR ARG ASN SEQRES 12 A 219 ARG GLY ASP PRO TRP ALA VAL SER PRO ARG ARG LYS LEU SEQRES 13 A 219 ILE SER VAL ASP SER ARG SER VAL SER LEU LEU PRO LEU SEQRES 14 A 219 GLU PHE ARG LYS ASP SER SER TYR GLU LEU GLN VAL ARG SEQRES 15 A 219 ALA GLY PRO MET PRO GLY SER SER TYR GLN GLY THR TRP SEQRES 16 A 219 SER GLU TRP SER ASP PRO VAL ILE PHE GLN THR GLN SER SEQRES 17 A 219 GLU GLU LEU LYS GLU HIS HIS HIS HIS HIS HIS SEQRES 1 B 219 CYS PRO ASP LEU VAL CYS TYR THR ASP TYR LEU GLN THR SEQRES 2 B 219 VAL ILE CYS ILE LEU GLU MET TRP ASN LEU HIS PRO SER SEQRES 3 B 219 THR LEU THR LEU THR TRP GLN ASP GLN TYR GLU GLU LEU SEQRES 4 B 219 LYS ASP GLU ALA THR SER CYS SER LEU HIS ARG SER ALA SEQRES 5 B 219 HIS ASN ALA THR HIS ALA THR TYR THR CYS HIS MET ASP SEQRES 6 B 219 VAL PHE HIS PHE MET ALA ASP ASP ILE PHE SER VAL GLN SEQRES 7 B 219 ILE THR ASP GLN SER GLY GLN TYR SER GLN GLU CYS GLY SEQRES 8 B 219 SER PHE LEU LEU ALA GLU SER ILE LYS PRO ALA PRO PRO SEQRES 9 B 219 PHE ASP VAL THR VAL THR PHE SER GLY GLN TYR GLN ILE SEQRES 10 B 219 SER TRP ARG SER ASP TYR GLU ASP PRO ALA PHE TYR MET SEQRES 11 B 219 LEU LYS GLY LYS LEU GLN TYR GLU LEU GLN TYR ARG ASN SEQRES 12 B 219 ARG GLY ASP PRO TRP ALA VAL SER PRO ARG ARG LYS LEU SEQRES 13 B 219 ILE SER VAL ASP SER ARG SER VAL SER LEU LEU PRO LEU SEQRES 14 B 219 GLU PHE ARG LYS ASP SER SER TYR GLU LEU GLN VAL ARG SEQRES 15 B 219 ALA GLY PRO MET PRO GLY SER SER TYR GLN GLY THR TRP SEQRES 16 B 219 SER GLU TRP SER ASP PRO VAL ILE PHE GLN THR GLN SER SEQRES 17 B 219 GLU GLU LEU LYS GLU HIS HIS HIS HIS HIS HIS SEQRES 1 C 219 CYS PRO ASP LEU VAL CYS TYR THR ASP TYR LEU GLN THR SEQRES 2 C 219 VAL ILE CYS ILE LEU GLU MET TRP ASN LEU HIS PRO SER SEQRES 3 C 219 THR LEU THR LEU THR TRP GLN ASP GLN TYR GLU GLU LEU SEQRES 4 C 219 LYS ASP GLU ALA THR SER CYS SER LEU HIS ARG SER ALA SEQRES 5 C 219 HIS ASN ALA THR HIS ALA THR TYR THR CYS HIS MET ASP SEQRES 6 C 219 VAL PHE HIS PHE MET ALA ASP ASP ILE PHE SER VAL GLN SEQRES 7 C 219 ILE THR ASP GLN SER GLY GLN TYR SER GLN GLU CYS GLY SEQRES 8 C 219 SER PHE LEU LEU ALA GLU SER ILE LYS PRO ALA PRO PRO SEQRES 9 C 219 PHE ASP VAL THR VAL THR PHE SER GLY GLN TYR GLN ILE SEQRES 10 C 219 SER TRP ARG SER ASP TYR GLU ASP PRO ALA PHE TYR MET SEQRES 11 C 219 LEU LYS GLY LYS LEU GLN TYR GLU LEU GLN TYR ARG ASN SEQRES 12 C 219 ARG GLY ASP PRO TRP ALA VAL SER PRO ARG ARG LYS LEU SEQRES 13 C 219 ILE SER VAL ASP SER ARG SER VAL SER LEU LEU PRO LEU SEQRES 14 C 219 GLU PHE ARG LYS ASP SER SER TYR GLU LEU GLN VAL ARG SEQRES 15 C 219 ALA GLY PRO MET PRO GLY SER SER TYR GLN GLY THR TRP SEQRES 16 C 219 SER GLU TRP SER ASP PRO VAL ILE PHE GLN THR GLN SER SEQRES 17 C 219 GLU GLU LEU LYS GLU HIS HIS HIS HIS HIS HIS MODRES 4NZD ASN B 54 ASN GLYCOSYLATION SITE MODRES 4NZD ASN A 54 ASN GLYCOSYLATION SITE MODRES 4NZD ASN C 54 ASN GLYCOSYLATION SITE HET NAG D 1 14 HET NAG D 2 14 HET BMA D 3 11 HET MAN D 4 11 HET FUC D 5 10 HET NAG E 1 14 HET NAG E 2 14 HET BMA E 3 11 HET MAN E 4 11 HET FUC E 5 10 HET NAG F 1 14 HET NAG F 2 14 HET BMA F 3 11 HET MAN F 4 11 HET FUC F 5 10 HET MAN A 301 11 HET NA A 307 1 HET NA A 308 1 HET NA A 309 1 HET CL A 310 1 HET CL A 311 1 HET CL A 312 1 HET CL A 313 1 HET TLA A 314 10 HET TLA A 315 10 HET MAN B 301 11 HET CL B 307 1 HET CL B 308 1 HET CL B 309 1 HET CL B 310 1 HET CL B 311 1 HET TLA B 312 10 HET MAN C 301 11 HET NA C 307 1 HET NA C 308 1 HET CL C 309 1 HET CL C 310 1 HET EDO C 311 4 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM NA SODIUM ION HETNAM CL CHLORIDE ION HETNAM TLA L(+)-TARTARIC ACID HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 4 NAG 6(C8 H15 N O6) FORMUL 4 BMA 3(C6 H12 O6) FORMUL 4 MAN 6(C6 H12 O6) FORMUL 4 FUC 3(C6 H12 O5) FORMUL 8 NA 5(NA 1+) FORMUL 11 CL 11(CL 1-) FORMUL 15 TLA 3(C4 H6 O6) FORMUL 29 EDO C2 H6 O2 FORMUL 30 HOH *158(H2 O) HELIX 1 1 ALA A 96 SER A 98 5 3 HELIX 2 2 LEU A 167 PHE A 171 5 5 HELIX 3 3 ALA B 96 SER B 98 5 3 HELIX 4 4 LEU B 167 PHE B 171 5 5 HELIX 5 5 ALA C 96 SER C 98 5 3 HELIX 6 6 LEU C 167 PHE C 171 5 5 SHEET 1 A 2 LEU A 4 THR A 8 0 SHEET 2 A 2 VAL A 14 LEU A 18 -1 O ILE A 17 N VAL A 5 SHEET 1 B 2 HIS A 49 HIS A 53 0 SHEET 2 B 2 ALA A 58 THR A 61 -1 O THR A 59 N ALA A 52 SHEET 1 C 2 ILE A 74 THR A 80 0 SHEET 2 C 2 SER A 87 LEU A 94 -1 O PHE A 93 N PHE A 75 SHEET 1 D 3 PHE A 105 PHE A 111 0 SHEET 2 D 3 TYR A 115 ARG A 120 -1 O GLN A 116 N THR A 110 SHEET 3 D 3 SER A 163 LEU A 166 -1 O LEU A 166 N TYR A 115 SHEET 1 E 4 ARG A 153 ILE A 157 0 SHEET 2 E 4 LEU A 135 ASN A 143 -1 N TYR A 137 O ILE A 157 SHEET 3 E 4 SER A 176 PRO A 185 -1 O GLN A 180 N GLN A 140 SHEET 4 E 4 VAL A 202 GLN A 205 -1 O PHE A 204 N TYR A 177 SHEET 1 F 4 LEU B 4 THR B 8 0 SHEET 2 F 4 THR B 13 LEU B 18 -1 O ILE B 15 N TYR B 7 SHEET 3 F 4 ALA B 58 HIS B 63 -1 O TYR B 60 N CYS B 16 SHEET 4 F 4 HIS B 49 HIS B 53 -1 N ALA B 52 O THR B 59 SHEET 1 G 3 THR B 27 GLN B 33 0 SHEET 2 G 3 ILE B 74 THR B 80 -1 O THR B 80 N THR B 27 SHEET 3 G 3 SER B 87 LEU B 94 -1 O GLN B 88 N ILE B 79 SHEET 1 H 3 PHE B 105 PHE B 111 0 SHEET 2 H 3 TYR B 115 ARG B 120 -1 O GLN B 116 N THR B 110 SHEET 3 H 3 SER B 163 LEU B 166 -1 O LEU B 166 N TYR B 115 SHEET 1 I 4 ARG B 153 ILE B 157 0 SHEET 2 I 4 LEU B 135 ASN B 143 -1 N TYR B 137 O ILE B 157 SHEET 3 I 4 SER B 176 PRO B 185 -1 O GLN B 180 N GLN B 140 SHEET 4 I 4 VAL B 202 GLN B 205 -1 O PHE B 204 N TYR B 177 SHEET 1 J 2 LEU C 4 THR C 8 0 SHEET 2 J 2 VAL C 14 LEU C 18 -1 O ILE C 15 N TYR C 7 SHEET 1 K 2 HIS C 49 HIS C 53 0 SHEET 2 K 2 ALA C 58 THR C 61 -1 O THR C 59 N ALA C 52 SHEET 1 L 2 ILE C 74 THR C 80 0 SHEET 2 L 2 SER C 87 LEU C 94 -1 O PHE C 93 N PHE C 75 SHEET 1 M 3 PHE C 105 PHE C 111 0 SHEET 2 M 3 TYR C 115 ARG C 120 -1 O GLN C 116 N THR C 110 SHEET 3 M 3 SER C 163 LEU C 166 -1 O VAL C 164 N ILE C 117 SHEET 1 N 4 ARG C 153 ILE C 157 0 SHEET 2 N 4 LEU C 135 ASN C 143 -1 N TYR C 137 O ILE C 157 SHEET 3 N 4 SER C 176 PRO C 185 -1 O GLY C 184 N GLN C 136 SHEET 4 N 4 VAL C 202 GLN C 205 -1 O PHE C 204 N TYR C 177 SSBOND 1 CYS A 1 CYS C 90 1555 7555 2.04 SSBOND 2 CYS A 6 CYS A 16 1555 1555 2.04 SSBOND 3 CYS A 46 CYS A 62 1555 1555 2.03 SSBOND 4 CYS A 90 CYS C 1 1555 6565 2.04 SSBOND 5 CYS B 1 CYS B 90 1555 1555 2.04 SSBOND 6 CYS B 6 CYS B 16 1555 1555 2.04 SSBOND 7 CYS B 46 CYS B 62 1555 1555 2.04 SSBOND 8 CYS C 6 CYS C 16 1555 1555 2.04 SSBOND 9 CYS C 46 CYS C 62 1555 1555 2.04 LINK ND2 ASN A 54 C1 NAG D 1 1555 1555 1.44 LINK ND2 ASN B 54 C1 NAG E 1 1555 1555 1.44 LINK ND2 ASN C 54 C1 NAG F 1 1555 1555 1.45 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.44 LINK O6 NAG D 1 C1 FUC D 5 1555 1555 1.44 LINK O4 NAG D 2 C1 BMA D 3 1555 1555 1.45 LINK O6 BMA D 3 C1 MAN D 4 1555 1555 1.44 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.43 LINK O6 NAG E 1 C1 FUC E 5 1555 1555 1.45 LINK O4 NAG E 2 C1 BMA E 3 1555 1555 1.45 LINK O6 BMA E 3 C1 MAN E 4 1555 1555 1.44 LINK O4 NAG F 1 C1 NAG F 2 1555 1555 1.44 LINK O6 NAG F 1 C1 FUC F 5 1555 1555 1.44 LINK O4 NAG F 2 C1 BMA F 3 1555 1555 1.46 LINK O6 BMA F 3 C1 MAN F 4 1555 1555 1.45 LINK OH TYR A 137 NA NA A 307 1555 1555 3.19 CISPEP 1 HIS A 24 PRO A 25 0 3.59 CISPEP 2 ALA A 43 THR A 44 0 12.89 CISPEP 3 LEU A 211 LYS A 212 0 -5.28 CISPEP 4 HIS B 24 PRO B 25 0 5.53 CISPEP 5 HIS C 24 PRO C 25 0 4.44 CISPEP 6 GLU C 213 HIS C 214 0 3.22 CRYST1 114.330 125.260 178.270 90.00 90.00 90.00 I 2 2 2 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008747 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007983 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005609 0.00000